Global Pneumonia Vaccine Market 2020 by Manufacturers, Type and Application, Forecast to 2025

Report ID: 49646 | Publish Date: May, 2020 | Pages: 156 | Format : PDF

Market Overview

The global Pneumonia Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Pneumonia Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Pneumonia Vaccine market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Pneumonia Vaccine market has been segmented into Pneumococcal Conjugate Vaccine (PCV13), Pneumococcal Polysaccharide Vaccine (PPSV23), etc.

Breakdown by Application, Pneumonia Vaccine has been segmented into Pneumonia, Meningitis, Sepsis, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Pneumonia Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Pneumonia Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pneumonia Vaccine market.

For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Pneumonia Vaccine Market Share Analysis

Pneumonia Vaccine competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Pneumonia Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pneumonia Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Pneumonia Vaccine are: Pfizer Inc., Astrazeneca Plc., Sanofi Pasteur, Glaxosmithkline Plc., Astellas Pharma Inc., Merck & Co., Inc., Emergent Biosolutions, Johnson & Johnson, Serum Institute of India Pvt. Ltd., CSL Limited, etc. Among other players domestic and global, Pneumonia Vaccine market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The key market players for global Pneumonia Vaccine market are listed below:

Pfizer Inc.

Astrazeneca Plc.

Sanofi Pasteur

Glaxosmithkline Plc.

Astellas Pharma Inc.

Merck & Co., Inc.

Emergent Biosolutions

Johnson & Johnson

Serum Institute of India Pvt. Ltd.

CSL Limited

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina)

Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)

Market segment by Type, covers:

Pneumococcal Conjugate Vaccine (PCV13)

Pneumococcal Polysaccharide Vaccine (PPSV23)

Market segment by Application, can be divided into

Pneumonia

Meningitis

Sepsis


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Pneumonia Vaccine Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Pneumonia Vaccine Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Pneumococcal Conjugate Vaccine (PCV13)

1.2.3 Pneumococcal Polysaccharide Vaccine (PPSV23)

1.3 Market Analysis by Application

1.3.1 Overview: Global Pneumonia Vaccine Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Pneumonia

1.3.3 Meningitis

1.3.4 Sepsis

1.4 Global Pneumonia Vaccine Market Size and Forecast (2015-2025)

1.4.1 Global Pneumonia Vaccine Revenue and Forecast (2015-2025)

1.4.2 Global Pneumonia Vaccine Sales and Forecast (2015-2025)

1.5 Global Pneumonia Vaccine Market Size Overview by Geography (2015-2020)

2 Manufacturers Profiles

2.1 Pfizer Inc.

2.1.1 Pfizer Inc. Details

2.1.2 Pfizer Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Pfizer Inc. SWOT Analysis

2.1.4 Pfizer Inc. Product and Services

2.1.5 Pfizer Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 Astrazeneca Plc.

2.2.1 Astrazeneca Plc. Details

2.2.2 Astrazeneca Plc. Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Astrazeneca Plc. SWOT Analysis

2.2.4 Astrazeneca Plc. Product and Services

2.2.5 Astrazeneca Plc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 Sanofi Pasteur

2.3.1 Sanofi Pasteur Details

2.3.2 Sanofi Pasteur Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Sanofi Pasteur SWOT Analysis

2.3.4 Sanofi Pasteur Product and Services

2.3.5 Sanofi Pasteur Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 Glaxosmithkline Plc.

2.4.1 Glaxosmithkline Plc. Details

2.4.2 Glaxosmithkline Plc. Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Glaxosmithkline Plc. SWOT Analysis

2.4.4 Glaxosmithkline Plc. Product and Services

2.4.5 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 Astellas Pharma Inc.

2.5.1 Astellas Pharma Inc. Details

2.5.2 Astellas Pharma Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Astellas Pharma Inc. SWOT Analysis

2.5.4 Astellas Pharma Inc. Product and Services

2.5.5 Astellas Pharma Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 Merck & Co., Inc.

2.6.1 Merck & Co., Inc. Details

2.6.2 Merck & Co., Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Merck & Co., Inc. SWOT Analysis

2.6.4 Merck & Co., Inc. Product and Services

2.6.5 Merck & Co., Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.7 Emergent Biosolutions

2.7.1 Emergent Biosolutions Details

2.7.2 Emergent Biosolutions Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Emergent Biosolutions SWOT Analysis

2.7.4 Emergent Biosolutions Product and Services

2.7.5 Emergent Biosolutions Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.8 Johnson & Johnson

2.8.1 Johnson & Johnson Details

2.8.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Johnson & Johnson SWOT Analysis

2.8.4 Johnson & Johnson Product and Services

2.8.5 Johnson & Johnson Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.9 Serum Institute of India Pvt. Ltd.

2.9.1 Serum Institute of India Pvt. Ltd. Details

2.9.2 Serum Institute of India Pvt. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Serum Institute of India Pvt. Ltd. SWOT Analysis

2.9.4 Serum Institute of India Pvt. Ltd. Product and Services

2.9.5 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.10 CSL Limited

2.10.1 CSL Limited Details

2.10.2 CSL Limited Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 CSL Limited SWOT Analysis

2.10.4 CSL Limited Product and Services

2.10.5 CSL Limited Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Global Pneumonia Vaccine Market, Company Landscape

3.1 Company Market Share Analysis: Global

3.1.1 Global Pneumonia Vaccine Sales and Market Share by Manufacturer (2018-2019)

3.1.2 Global Pneumonia Vaccine Revenue and Market Share by Manufacturer (2018-2019)

3.2 Company Market Share Analysis: China

3.2.1 Key Players Pneumonia Vaccine Sales in China (2018-2019)

3.2.2 China Pneumonia Vaccine Revenue Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 Pneumonia Vaccine Manufacturer Market Share in 2019

3.3.2 Top 6 Pneumonia Vaccine Manufacturer Market Share in 2019

4 Market Size by Geography

4.1 Global Pneumonia Vaccine Market Size by Geography (2015-2020)

4.1.1 Global Pneumonia Vaccine Sales by Geography (2015-2020)

4.1.2 Global Pneumonia Vaccine Revenue by Regions (2015-2020)

4.2 Global Pneumonia Vaccine Market Size and Forecast by Regions (2020-2025)

4.2.1 Global Pneumonia Vaccine Sales and Forecast by Regions (2020-2025)

4.2.2 Global Pneumonia Vaccine Revenue and Forecast by Regions (2020-2025)

4.3 North America Pneumonia Vaccine Market Size and Forecast (2015-2025)

4.4 Europe Pneumonia Vaccine Market Size and Forecast (2015-2025)

4.5 Asia-Pacific Pneumonia Vaccine Market Size and Forecast (2015-2025)

4.6 South America Pneumonia Vaccine Market Size and Forecast (2015-2025)

4.7 Middle East and Africa Pneumonia Vaccine Market Size and Forecast (2015-2025)

5 North America by Country

5.1 North America Pneumonia Vaccine Market Size by Country (2015-2020)

5.1.1 North America Pneumonia Vaccine Sales and Market Share by Country (2015-2020)

5.1.2 North America Pneumonia Vaccine Revenue and Market Share by Country (2015-2020)

5.2 North America Pneumonia Vaccine Market Size and Forecast by Country (2020-2025)

5.2.1 North America Pneumonia Vaccine Sales and Forecast by Country (2020-2025)

5.2.2 North America Pneumonia Vaccine Revenue and Forecast by Country (2020-2025)

5.3 United States Pneumonia Vaccine Market Size and Forecast (2015-2025)

5.4 Canada Pneumonia Vaccine Market Size and Forecast (2015-2025)

5.5 Mexico Pneumonia Vaccine Market Size and Forecast (2015-2025)

6 Europe by Country

6.1 Europe Pneumonia Vaccine Market Size by Country (2015-2020)

6.1.1 Europe Pneumonia Vaccine Sales by Country (2015-2020)

6.1.2 Europe Pneumonia Vaccine Revenue by Country (2015-2020)

6.2 Europe Pneumonia Vaccine Market Size and Forecast by Country (2020-2025)

6.2.1 Europe Pneumonia Vaccine Sales and Forecast by Country (2020-2025)

6.2.2 Europe Pneumonia Vaccine Revenue and Forecast by Country (2020-2025)

6.3 Germany Pneumonia Vaccine Market Size and Forecast (2015-2025)

6.4 United Kingdom Pneumonia Vaccine Market Size and Forecast (2015-2025)

6.5 France Pneumonia Vaccine Market Size and Forecast (2015-2025)

6.6 Russia Pneumonia Vaccine Market Size and Forecast (2015-2025)

6.7 Italy Pneumonia Vaccine Market Size and Forecast (2015-2025)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Pneumonia Vaccine Market Size by Region (2015-2020)

7.1.1 Asia-Pacific Pneumonia Vaccine Sales by Region (2015-2020)

7.1.2 Asia-Pacific Pneumonia Vaccine Revenue by Region (2015-2020)

7.2 Asia-Pacific Pneumonia Vaccine Market Size and Forecast by Region (2020-2025)

7.2.1 Asia-Pacific Pneumonia Vaccine Sales and Forecast by Region (2020-2025)

7.2.2 Asia-Pacific Pneumonia Vaccine Revenue and Forecast by Region (2020-2025)

7.3 China Pneumonia Vaccine Market Size and Forecast (2015-2025)

7.4 Japan Pneumonia Vaccine Market Size and Forecast (2015-2025)

7.5 Korea Pneumonia Vaccine Market Size and Forecast (2015-2025)

7.6 India Pneumonia Vaccine Market Size and Forecast (2015-2025)

7.7 Southeast Asia Pneumonia Vaccine Market Size and Forecast (2015-2025)

7.8 Australia Pneumonia Vaccine Market Size and Forecast (2015-2025)

8 South America by Country

8.1 South America Pneumonia Vaccine Market Size by Country (2015-2020)

8.1.1 South America Pneumonia Vaccine Sales by Country (2015-2020)

8.1.2 South America Pneumonia Vaccine Revenue by Country (2015-2020)

8.2 South America Pneumonia Vaccine Market Size and Forecast by Country (2020-2025)

8.2.1 South America Pneumonia Vaccine Sales and Forecast by Country (2020-2025)

8.2.2 South America Pneumonia Vaccine Revenue and Forecast by Country (2020-2025)

8.3 Brazil Pneumonia Vaccine Market Size and Forecast (2015-2025)

8.4 Argentina Pneumonia Vaccine Market Size and Forecast (2015-2025)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Pneumonia Vaccine Market Size by Country (2015-2020)

9.1.1 Middle East & Africa Pneumonia Vaccine Sales by Country (2015-2020)

9.1.2 Middle East & Africa Pneumonia Vaccine Revenue by Country (2015-2020)

9.2 Middle East & Africa Pneumonia Vaccine Market Size and Forecast by Country (2020-2025)

9.2.1 Middle East & Africa Pneumonia Vaccine Sales and Forecast by Country (2020-2025)

9.2.2 Middle East & Africa Pneumonia Vaccine Revenue and Forecast by Country (2020-2025)

9.3 Saudi Arabia Pneumonia Vaccine Market Size and Forecast (2015-2025)

9.4 Turkey Pneumonia Vaccine Market Size and Forecast (2015-2025)

9.5 Egypt Pneumonia Vaccine Market Size and Forecast (2015-2025)

9.6 South Africa Pneumonia Vaccine Market Size and Forecast (2015-2025)

10 Market Segment by Type

10.1 Global Pneumonia Vaccine Market Size by Type (2015-2020)

10.1.1 Global Pneumonia Vaccine Sales by Type (2015-2020)

10.1.2 Global Pneumonia Vaccine Revenue by Type (2015-2020)

10.1.3 Global Pneumonia Vaccine Price by Type (2015-2020)

10.2 Global Pneumonia Vaccine Market Size and Forecast by Type (2020-2025)

10.2.1 Global Pneumonia Vaccine Sales and Forecast by Type (2020-2025)

10.2.2 Global Pneumonia Vaccine Revenue and Forecast by Type (2020-2025)

10.2.3 Global Pneumonia Vaccine Price and Forecast by Type (2020-2025)

10.3 China Pneumonia Vaccine Market Size and Forecast by Type (2015-2025)

10.3.1 China Pneumonia Vaccine Market Size by Type (2015-2020)

10.3.2 China Pneumonia Vaccine Market Size and Forecast by Type (2020-2025)

11 Market Segment by Application

11.1 Global Pneumonia Vaccine Market Size by Application (2015-2020)

11.1.1 Global Pneumonia Vaccine Sales by Application (2015-2020)

11.1.2 Global Pneumonia Vaccine Revenue by Application (2015-2020)

11.1.3 Global Pneumonia Vaccine Price by Application (2015-2020)

11.2 Global Pneumonia Vaccine Market Size and Forecast by Application (2020-2025)

11.2.1 Global Pneumonia Vaccine Sales and Forecast by Application (2020-2025)

11.2.2 Global Pneumonia Vaccine Revenue and Forecast by Application (2020-2025)

11.2.3 Global Pneumonia Vaccine Price and Forecast by Application (2020-2025)

11.3 China Pneumonia Vaccine Market Size and Forecast by Application (2015-2025)

11.3.1 China Pneumonia Vaccine Market Size by Application (2015-2020)

11.3.2 China Pneumonia Vaccine Market Size and Forecast by Application (2020-2025)

12 Sales Channel, Distributors, Costumers, and Market Dynamics

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Distributors, Traders and Dealers

12.4.1 Market Opportunities

12.4.2 Market Risk

12.4.3 Market Driving Force

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US

List of Tables

Table 1. Global Pneumonia Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Pneumonia Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Pneumonia Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Pneumonia Vaccine Market Size Overview by Geography (2015-2020) (USD Million)

Table 5. Pfizer Inc. Basic Information, Manufacturing Base and Competitors

Table 6. Pfizer Inc. Pneumonia Vaccine Major Business

Table 7. Pfizer Inc. Pneumonia Vaccine Total Revenue (USD Million) (2018-2019)

Table 8. Pfizer Inc. SWOT Analysis

Table 9. Pfizer Inc. Pneumonia Vaccine Product and Services

Table 10. Pfizer Inc. Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)

Table 11. Astrazeneca Plc. Basic Information, Manufacturing Base and Competitors

Table 12. Astrazeneca Plc. Pneumonia Vaccine Major Business

Table 13. Astrazeneca Plc. Pneumonia Vaccine Total Revenue (USD Million) (2018-2019)

Table 14. Astrazeneca Plc. SWOT Analysis

Table 15. Astrazeneca Plc. Pneumonia Vaccine Product and Services

Table 16. Astrazeneca Plc. Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)

Table 17. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors

Table 18. Sanofi Pasteur Pneumonia Vaccine Major Business

Table 19. Sanofi Pasteur Pneumonia Vaccine Total Revenue (USD Million) (2018-2019)

Table 20. Sanofi Pasteur SWOT Analysis

Table 21. Sanofi Pasteur Pneumonia Vaccine Product and Services

Table 22. Sanofi Pasteur Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)

Table 23. Glaxosmithkline Plc. Basic Information, Manufacturing Base and Competitors

Table 24. Glaxosmithkline Plc. Pneumonia Vaccine Major Business

Table 25. Glaxosmithkline Plc. Pneumonia Vaccine Total Revenue (USD Million) (2018-2019)

Table 26. Glaxosmithkline Plc. SWOT Analysis

Table 27. Glaxosmithkline Plc. Pneumonia Vaccine Product and Services

Table 28. Glaxosmithkline Plc. Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)

Table 29. Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors

Table 30. Astellas Pharma Inc. Pneumonia Vaccine Major Business

Table 31. Astellas Pharma Inc. Pneumonia Vaccine Total Revenue (USD Million) (2018-2019)

Table 32. Astellas Pharma Inc. SWOT Analysis

Table 33. Astellas Pharma Inc. Pneumonia Vaccine Product and Services

Table 34. Astellas Pharma Inc. Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)

Table 35. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors

Table 36. Merck & Co., Inc. Pneumonia Vaccine Major Business

Table 37. Merck & Co., Inc. Pneumonia Vaccine Total Revenue (USD Million) (2018-2019)

Table 38. Merck & Co., Inc. SWOT Analysis

Table 39. Merck & Co., Inc. Pneumonia Vaccine Product and Services

Table 40. Merck & Co., Inc. Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)

Table 41. Emergent Biosolutions Basic Information, Manufacturing Base and Competitors

Table 42. Emergent Biosolutions Pneumonia Vaccine Major Business

Table 43. Emergent Biosolutions Pneumonia Vaccine Total Revenue (USD Million) (2018-2019)

Table 44. Emergent Biosolutions SWOT Analysis

Table 45. Emergent Biosolutions Pneumonia Vaccine Product and Services

Table 46. Emergent Biosolutions Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)

Table 47. Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table 48. Johnson & Johnson Pneumonia Vaccine Major Business

Table 49. Johnson & Johnson Pneumonia Vaccine Total Revenue (USD Million) (2018-2019)

Table 50. Johnson & Johnson SWOT Analysis

Table 51. Johnson & Johnson Pneumonia Vaccine Product and Services

Table 52. Johnson & Johnson Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)

Table 53. Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors

Table 54. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Major Business

Table 55. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Total Revenue (USD Million) (2018-2019)

Table 56. Serum Institute of India Pvt. Ltd. SWOT Analysis

Table 57. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product and Services

Table 58. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)

Table 59. CSL Limited Basic Information, Manufacturing Base and Competitors

Table 60. CSL Limited Pneumonia Vaccine Major Business

Table 61. CSL Limited Pneumonia Vaccine Total Revenue (USD Million) (2018-2019)

Table 62. CSL Limited SWOT Analysis

Table 63. CSL Limited Pneumonia Vaccine Product and Services

Table 64. CSL Limited Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)

Table 65. Global Pneumonia Vaccine Sales by Manufacturer (2018-2019) (K Doses)

Table 66. Global Pneumonia Vaccine Revenue by Manufacturer (2018-2019) (USD Million)

Table 67. Key Players Pneumonia Vaccine Sales in China (2018-2019) (K Doses)

Table 68. Key Players Pneumonia Vaccine Sales Market Share in China (2018-2019)

Table 69. Key Players Revenue of Pneumonia Vaccine in China (2018-2019) (USD Million)

Table 70. Global Pneumonia Vaccine Sales by Regions (2015-2020) (K Doses)

Table 71. Global Pneumonia Vaccine Sales Market Share by Regions (2015-2020)

Table 72. Global Pneumonia Vaccine Revenue by Regions (2015-2020) (USD Million)

Table 73. Global Pneumonia Vaccine Sales and Forecast by Regions (2020-2025) (K Doses)

Table 74. Global Pneumonia Vaccine Sales Market Share by Regions (2020-2025)

Table 75. Global Pneumonia Vaccine Revenue and Forecast by Regions (2020-2025) (USD Million)

Table 76. Global Pneumonia Vaccine Revenue Market Share by Regions (2020-2025) (USD Million)

Table 77. North America Pneumonia Vaccine Sales by Countries (2015-2020) (K Doses)

Table 78. North America Pneumonia Vaccine Sales Market Share by Countries (2015-2020)

Table 79. North America Pneumonia Vaccine Revenue by Countries (2015-2020) (USD Million)

Table 80. North America Pneumonia Vaccine Revenue Market Share by Countries (2015-2020)

Table 81. North America Pneumonia Vaccine Sales by Country (2020-2025) (K Doses)

Table 82. North America Pneumonia Vaccine Sales Market Share by Country (2020-2025)

Table 83. North America Pneumonia Vaccine Revenue by Country (2020-2025) (USD Million)

Table 84. North America Pneumonia Vaccine Revenue Market Share by Country (2020-2025)

Table 85. Europe Pneumonia Vaccine Sales by Countries (2015-2020) (K Doses)

Table 86. Europe Pneumonia Vaccine Sales Market Share by Countries (2015-2020)

Table 87. Europe Pneumonia Vaccine Revenue by Countries (2015-2020) (USD Million)

Table 88. Europe Pneumonia Vaccine Revenue Market Share by Countries (2015-2020)

Table 89. Europe Pneumonia Vaccine Sales by Country (2020-2025) (K Doses)

Table 90. Europe Pneumonia Vaccine Sales Market Share by Country (2020-2025)

Table 91. Europe Pneumonia Vaccine Revenue by Country (2020-2025) (USD Million)

Table 92. Europe Pneumonia Vaccine Revenue Market Share by Country (2020-2025)

Table 93. Asia-Pacific Pneumonia Vaccine Sales by Countries (2015-2020) (K Doses)

Table 94. Asia-Pacific Pneumonia Vaccine Sales Market Share by Countries (2015-2020)

Table 95. Asia-Pacific Pneumonia Vaccine Revenue by Countries (2015-2020) (USD Million)

Table 96. Asia-Pacific Pneumonia Vaccine Revenue Market Share by Countries (2015-2020)

Table 97. Asia-Pacific Pneumonia Vaccine Sales by Country (2020-2025) (K Doses)

Table 98. Asia-Pacific Pneumonia Vaccine Sales Market Share by Country (2020-2025)

Table 99. Asia-Pacific Pneumonia Vaccine Revenue by Country (2020-2025) (USD Million)

Table 100. Asia-Pacific Pneumonia Vaccine Revenue Market Share by Country (2020-2025)

Table 101. South America Pneumonia Vaccine Sales by Countries (2015-2020) (K Doses)

Table 102. South America Pneumonia Vaccine Sales Market Share by Countries (2015-2020)

Table 103. South America Pneumonia Vaccine Revenue by Countries (2015-2020) (USD Million)

Table 104. South America Pneumonia Vaccine Revenue Market Share by Countries (2015-2020)

Table 105. South America Pneumonia Vaccine Sales by Country (2020-2025) (K Doses)

Table 106. South America Pneumonia Vaccine Sales Market Share by Country (2020-2025)

Table 107. South America Pneumonia Vaccine Revenue by Country (2020-2025) (USD Million)

Table 108. South America Pneumonia Vaccine Revenue Market Share by Country (2020-2025)

Table 109. Middle East & Africa Pneumonia Vaccine Sales by Countries (2015-2020) (K Doses)

Table 110. Middle East & Africa Pneumonia Vaccine Sales Market Share by Countries (2015-2020)

Table 111. Middle East & Africa Pneumonia Vaccine Revenue by Countries (2015-2020) (USD Million)

Table 112. Middle East & Africa Pneumonia Vaccine Revenue Market Share by Countries (2015-2020)

Table 113. Middle East & Africa Pneumonia Vaccine Sales by Country (2020-2025) (K Doses)

Table 114. Middle East & Africa Pneumonia Vaccine Sales Market Share by Country (2020-2025)

Table 115. Middle East & Africa Pneumonia Vaccine Revenue by Country (2020-2025) (USD Million)

Table 116. Middle East & Africa Pneumonia Vaccine Revenue Market Share by Country (2020-2025)

Table 117. China Pneumonia Vaccine Sales by Type (2015-2020) (K Doses)

Table 118. China Pneumonia Vaccine Sales Market Share by Type (2015-2020)

Table 119. China Pneumonia Vaccine Revenue by Type (2015-2020) (USD Million)

Table 120. China Pneumonia Vaccine Revenue Market Share by Type (2015-2020)

Table 121. China Pneumonia Vaccine Sales by Type (2020-2025) (K Doses)

Table 122. China Pneumonia Vaccine Sales Market Share by Type (2020-2025)

Table 123. China Pneumonia Vaccine Revenue by Type (2020-2025) (USD Million)

Table 124. China Pneumonia Vaccine Revenue Market Share by Type (2020-2025)

Table 125. Global Pneumonia Vaccine Sales by Application (2015-2020) (K Doses)

Table 126. Global Pneumonia Vaccine Sales Market Share by Application (2015-2020)

Table 127. Global Pneumonia Vaccine Revenue by Application (2015-2020) (USD Million)

Table 128. Global Pneumonia Vaccine Revenue Market Share by Application (2015-2020)

Table 129. Global Pneumonia Vaccine Price by Application (2015-2020) (USD/Dose)

Table 130. Global Pneumonia Vaccine Sales by Application (2020-2025) (K Doses)

Table 131. Global Pneumonia Vaccine Sales Market Share by Application (2020-2025)

Table 132. Global Pneumonia Vaccine Revenue by Application (2020-2025) (USD Million)

Table 133. Global Pneumonia Vaccine Revenue Market Share by Application (2020-2025)

Table 134. Global Pneumonia Vaccine Price by Application (2020-2025) (USD/Dose)

Table 135. China Pneumonia Vaccine Sales by Application (2015-2020) (K Doses)

Table 136. China Pneumonia Vaccine Sales Market Share by Application (2015-2020)

Table 137. China Pneumonia Vaccine Revenue by Application (2015-2020) (USD Million)

Table 138. China Pneumonia Vaccine Revenue Market Share by Application (2015-2020)

Table 139. China Pneumonia Vaccine Sales by Application (2020-2025) (K Doses)

Table 140. China Pneumonia Vaccine Sales Market Share by Application (2020-2025)

Table 141. China Pneumonia Vaccine Revenue by Application (2020-2025) (USD Million)

Table 142. China Pneumonia Vaccine Revenue Market Share by Application (2020-2025)

Table 143. Direct Channel Pros & Cons

Table 144. Indirect Channel Pros & Cons

Table 145. Distributors/Traders/ Dealers List

Table 146. Customers of Pneumonia Vaccine

Table 147. Market Opportunities in Next Few Years

Table 148. Market Risks Analysis

Table 149. Market Drivers

List of Figures

Figure 1. Pneumonia Vaccine Picture

Figure 2. Global Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 3. Pneumococcal Conjugate Vaccine (PCV13) Picture

Figure 4. Pneumococcal Polysaccharide Vaccine (PPSV23) Picture

Figure 5. Pneumonia Vaccine Sales Market Share by Application in 2019

Figure 6. Pneumonia Picture

Figure 7. Meningitis Picture

Figure 8. Sepsis Picture

Figure 9. Global Pneumonia Vaccine Market Status and Outlook (2015-2025) (USD Million)

Figure 10. Global Pneumonia Vaccine Sales Growth Rate (2015-2025) (K Doses)

Figure 11. Global Pneumonia Vaccine Sales Market Share by Manufacturer in 2019

Figure 12. Global Pneumonia Vaccine Revenue Market Share by Manufacturer in 2019

Figure 13. Key Players Pneumonia Vaccine Revenue Market Share in China in 2019

Figure 14. Global Top 5 Pneumonia Vaccine Manufacturer Market Share in 2019

Figure 15. Top 3 Pneumonia Vaccine Players Market Share in China in 2019

Figure 16. Global Pneumonia Vaccine Revenue Market Share by Regions in 2019

Figure 17. North America Pneumonia Vaccine Sales YoY Growth (2015-2025) (K Doses)

Figure 18. North America Pneumonia Vaccine Revenue YoY Growth (2015-2025) (USD Million)

Figure 19. Europe Pneumonia Vaccine Sales YoY Growth (2015-2020) (K Doses)

Figure 20. Europe Pneumonia Vaccine Revenue YoY Growth (2015-2020) (USD Million)

Figure 21. Asia-Pacific Pneumonia Vaccine Sales YoY Growth (2015-2020) (K Doses)

Figure 22. Asia-Pacific Pneumonia Vaccine Revenue YoY Growth (2015-2020) (USD Million)

Figure 23. South America Pneumonia Vaccine Sales YoY Growth (2015-2020) (K Doses)

Figure 24. South America Pneumonia Vaccine Revenue YoY Growth (2015-2020) (USD Million)

Figure 25. Middle East & Africa Pneumonia Vaccine Sales YoY Growth (2015-2020) (K Doses)

Figure 26. Middle East & Africa Pneumonia Vaccine Revenue YoY Growth (2015-2020) (USD Million)

Figure 27. North America Pneumonia Vaccine Sales Market Share by Country in 2019

Figure 28. North America Pneumonia Vaccine Revenue Market Share by Country in 2019

Figure 29. United States Pneumonia Vaccine Market Size and Growth Rate (2015-2025) (USD Million)

Figure 30. Canada Pneumonia Vaccine Market Size and Growth Rate (2015-2025) (USD Million)

Figure 31. Mexico Pneumonia Vaccine Market Size and Growth Rate (2015-2020) (USD Million)

Figure 32. Europe Pneumonia Vaccine Revenue Market Share by Country in 2019

Figure 33. Germany Pneumonia Vaccine Market Size Growth Rate (2015-2025) (USD Million)

Figure 34. United Kingdom Pneumonia Vaccine Market Size Growth Rate (2015-2025) (USD Million)

Figure 35. France Pneumonia Vaccine Market Size Growth Rate (2015-2025) (USD Million)

Figure 36. Russia Pneumonia Vaccine Market Size Growth Rate (2015-2025) (USD Million)

Figure 37. Italy Pneumonia Vaccine Market Size Growth Rate (2015-2025) (USD Million)

Figure 38. Asia-Pacific Pneumonia Vaccine Sales Market Share by Region 2018

Figure 39. Asia-Pacific Pneumonia Vaccine Revenue Market Share by Region 2018

Figure 40. China Pneumonia Vaccine Market Size Growth Rate (2015-2025) (USD Million)

Figure 41. Japan Pneumonia Vaccine Market Size Growth Rate (2015-2025) (USD Million)

Figure 42. Korea Pneumonia Vaccine Market Size Growth Rate (2015-2025) (USD Million)

Figure 43. India Pneumonia Vaccine Market Size Growth Rate (2015-2025) (USD Million)

Figure 44. Southeast Asia Pneumonia Vaccine Market Size Growth Rate (2015-2025) (USD Million)

Figure 45. Australia Pneumonia Vaccine Market Size Growth Rate (2015-2025) (USD Million)

Figure 46. South America Pneumonia Vaccine Sales Market Share by Country in 2019

Figure 47. South America Pneumonia Vaccine Revenue Market Share by Country in 2019

Figure 48. Brazil Pneumonia Vaccine Market Size Growth Rate (2015-2025) (USD Million)

Figure 49. Argentina Pneumonia Vaccine Market Size Growth Rate (2015-2025) (USD Million)

Figure 50. Saudi Arabia Pneumonia Vaccine Market Size Growth Rate (2015-2025) (USD Million)

Figure 51. Turkey Pneumonia Vaccine Market Size Growth Rate (2015-2025) (USD Million)

Figure 52. Egypt Pneumonia Vaccine Market Size Growth Rate (2015-2025) (USD Million)

Figure 53. South Africa Pneumonia Vaccine Market Size Growth Rate (2015-2025) (USD Million)

Figure 54. Global Revenue Market Share of Pneumonia Vaccine by Type in 2019

Figure 55. Global Revenue Market Share of Pneumonia Vaccine by Application in 2019

Figure 56. Sales Channel: Direct Channel vs Indirect Channel

Our Clients